• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种 COVID-19 疫苗后的死亡病例的尸检调查。

Postmortem investigation of fatalities following vaccination with COVID-19 vaccines.

机构信息

Institute of Legal Medicine, University Hospital Münster, Münster, Germany.

Institute of Immunology and Transfusion Medicine, University Medicine of Greifswald, Greifswald, Germany.

出版信息

Int J Legal Med. 2021 Nov;135(6):2335-2345. doi: 10.1007/s00414-021-02706-9. Epub 2021 Sep 30.

DOI:10.1007/s00414-021-02706-9
PMID:34591186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8482743/
Abstract

Thorough postmortem investigations of fatalities following vaccination with coronavirus disease 2019 (COVID-19) vaccines are of great social significance. From 11.03.2021 to 09.06.2021, postmortem investigations of 18 deceased persons who recently received a vaccination against COVID-19 were performed. Vaxzevria was vaccinated in nine, Comirnaty in five, Spikevax in three, and Janssen in one person. In all cases, full autopsies, histopathological examinations, and virological analyses for the severe acute respiratory syndrome coronavirus 2 were carried out. Depending on the case, additional laboratory tests (anaphylaxis diagnostics, VITT [vaccine-induced immune thrombotic thrombocytopenia] diagnostics, glucose metabolism diagnostics) and neuropathological examinations were conducted. In 13 deceased, the cause of death was attributed to preexisting diseases while postmortem investigations did not indicate a causal relationship to the vaccination. In one case after vaccination with Comirnaty, myocarditis was found to be the cause of death. A causal relationship to vaccination was considered possible, but could not be proven beyond doubt. VITT was found in three deceased persons following vaccination with Vaxzevria and one deceased following vaccination with Janssen. Of those four cases with VITT, only one was diagnosed before death. The synopsis of the anamnestic data, the autopsy results, laboratory diagnostic examinations, and histopathological and neuropathological examinations revealed that VITT was the very likely cause of death in only two of the four cases. In the other two cases, no neuropathological correlate of VITT explaining death was found, while possible causes of death emerged that were not necessarily attributable to VITT. The results of our study demonstrate the necessity of postmortem investigations on all fatalities following vaccination with COVID-19 vaccines. In order to identify a possible causal relationship between vaccination and death, in most cases an autopsy and histopathological examinations have to be combined with additional investigations, such as laboratory tests and neuropathological examinations.

摘要

对接种 2019 年冠状病毒病(COVID-19)疫苗后死亡病例进行彻底的尸检调查具有重要的社会意义。从 2021 年 3 月 11 日至 6 月 9 日,对最近接种 COVID-19 疫苗的 18 名死者进行了尸检调查。接种 Vaxzevria 的有 9 人,接种 Comirnaty 的有 5 人,接种 Spikevax 的有 3 人,接种 Janssen 的有 1 人。在所有情况下,均进行了全面的尸检、组织病理学检查和严重急性呼吸综合征冠状病毒 2 的病毒学分析。根据具体情况,还进行了其他实验室检查(过敏反应诊断、VITT[疫苗诱导的免疫血栓性血小板减少症]诊断、葡萄糖代谢诊断)和神经病理学检查。在 13 名死者中,死因归因于先前存在的疾病,尸检并未表明与接种疫苗有因果关系。在一例接种 Comirnaty 后,发现心肌炎是死亡的原因。虽然考虑与接种疫苗有关,但不能毫无疑问地证明。在接种 Vaxzevria 的 4 名死者和接种 Janssen 的 1 名死者中发现了 VITT。在这 4 例 VITT 中,只有 1 例在死亡前得到诊断。病史资料摘要、尸检结果、实验室诊断检查、组织病理学和神经病理学检查结果表明,只有在 4 例中的 2 例中,VITT 极有可能是死亡的原因。在另外 2 例中,没有发现可解释死亡的与 VITT 相关的神经病理学相关性,而出现了其他可能的死因,不一定归因于 VITT。我们的研究结果表明,对所有接种 COVID-19 疫苗后死亡的病例进行尸检调查是必要的。为了确定接种疫苗与死亡之间的可能因果关系,在大多数情况下,尸检和组织病理学检查必须结合其他检查,如实验室检查和神经病理学检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5e/8523398/616f1824614d/414_2021_2706_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5e/8523398/12f81567584e/414_2021_2706_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5e/8523398/616f1824614d/414_2021_2706_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5e/8523398/12f81567584e/414_2021_2706_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5e/8523398/616f1824614d/414_2021_2706_Fig2_HTML.jpg

相似文献

1
Postmortem investigation of fatalities following vaccination with COVID-19 vaccines.接种 COVID-19 疫苗后的死亡病例的尸检调查。
Int J Legal Med. 2021 Nov;135(6):2335-2345. doi: 10.1007/s00414-021-02706-9. Epub 2021 Sep 30.
2
Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study.英国接种新冠疫苗后发生的脑静脉血栓形成:一项多中心队列研究。
Lancet. 2021 Sep 25;398(10306):1147-1156. doi: 10.1016/S0140-6736(21)01608-1. Epub 2021 Aug 6.
3
Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®).与新推出的 SARS-CoV-2 疫苗(Comirnaty®)接种相关的死亡。
Leg Med (Tokyo). 2021 Jul;51:101895. doi: 10.1016/j.legalmed.2021.101895. Epub 2021 Apr 17.
4
Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem.接种 2 剂 ChAdOx1 nCoV19 疫苗后引发的疫苗诱导性免疫性血栓性血小板减少症:病情较轻,但仍是一个问题。
Vaccine. 2023 May 11;41(20):3285-3291. doi: 10.1016/j.vaccine.2023.03.071. Epub 2023 Apr 19.
5
Autopsy findings of post-COVID-19 vaccination deaths in Tokyo Metropolis, Japan, 2021.日本东京都 2021 年 COVID-19 疫苗接种后死亡的尸检结果。
Leg Med (Tokyo). 2022 Nov;59:102134. doi: 10.1016/j.legalmed.2022.102134. Epub 2022 Aug 20.
6
Case Study of Autopsy Findings in a Population of Post-COVID-19 Vaccination in Thailand.泰国接种 COVID-19 疫苗后的人群尸检结果的病例研究。
Am J Forensic Med Pathol. 2024 Mar 1;45(1):45-50. doi: 10.1097/PAF.0000000000000900. Epub 2023 Dec 21.
7
Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.疑似 COVID-19 疫苗诱导(免疫性)血栓性血小板减少症的实验室检测。
Int J Lab Hematol. 2021 Aug;43(4):559-570. doi: 10.1111/ijlh.13629. Epub 2021 Jun 17.
8
Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.疫苗接种后 COVID-19 疫苗诱导的免疫性血栓性血小板减少症和脑静脉窦血栓形成:系统评价。
J Neurol Sci. 2021 Sep 15;428:117607. doi: 10.1016/j.jns.2021.117607. Epub 2021 Aug 3.
9
Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination.分析全国监测系统报告的 COVID-19 二价加强针接种后血液学不良事件。
Ann Hematol. 2023 Apr;102(4):955-959. doi: 10.1007/s00277-023-05136-2. Epub 2023 Feb 16.
10
Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.死于 SARS-CoV-2 感染——德国汉堡首例连续 80 例尸检研究。
Int J Legal Med. 2020 Jul;134(4):1275-1284. doi: 10.1007/s00414-020-02317-w. Epub 2020 Jun 4.

引用本文的文献

1
Serious adverse events following immunization and predictors of mortality associated with COVID-19 vaccination in India: a secondary data analysis of nationwide causality assessments.印度新冠疫苗接种后的严重不良事件及与新冠疫苗接种相关的死亡预测因素:全国因果关系评估的二次数据分析
Ther Adv Vaccines Immunother. 2025 Mar 2;13:25151355251321697. doi: 10.1177/25151355251321697. eCollection 2025.
2
Report on adverse events of COVID-19 vaccines in Iran: a comprehensive national prospective longitudinal analysis.伊朗新冠疫苗不良事件报告:一项全面的全国前瞻性纵向分析
Front Immunol. 2025 Feb 14;16:1504973. doi: 10.3389/fimmu.2025.1504973. eCollection 2025.
3

本文引用的文献

1
Arrhythmia Variant Associations and Reclassifications in the eMERGE-III Sequencing Study.eMERGE-III 测序研究中的心律失常变异体关联和重新分类。
Circulation. 2022 Mar 22;145(12):877-891. doi: 10.1161/CIRCULATIONAHA.121.055562. Epub 2021 Dec 21.
2
Contemporary Management of Cardiogenic Shock: A RAND Appropriateness Panel Approach.当代心原性休克的管理:一个 RAND 适宜性专家组方法。
Circ Heart Fail. 2021 Dec;14(12):e008635. doi: 10.1161/CIRCHEARTFAILURE.121.008635. Epub 2021 Nov 22.
3
Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque Composition.
An overview and single-arm meta-analysis of immune-mediated adverse events following COVID-19 vaccination.
新型冠状病毒肺炎疫苗接种后免疫介导不良事件的概述及单臂荟萃分析
Front Pharmacol. 2024 Jun 12;15:1308768. doi: 10.3389/fphar.2024.1308768. eCollection 2024.
4
Deciphering deaths associated with severe serious adverse events following SARS-CoV-2 vaccination: A retrospective cohort study.解读与新型冠状病毒2疫苗接种后严重不良事件相关的死亡:一项回顾性队列研究。
Vaccine X. 2024 Jan 20;16:100446. doi: 10.1016/j.jvacx.2024.100446. eCollection 2024 Jan.
5
Case Study of Autopsy Findings in a Population of Post-COVID-19 Vaccination in Thailand.泰国接种 COVID-19 疫苗后的人群尸检结果的病例研究。
Am J Forensic Med Pathol. 2024 Mar 1;45(1):45-50. doi: 10.1097/PAF.0000000000000900. Epub 2023 Dec 21.
6
The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study.ChAdOx1-S(AZD1222)疫苗接种后血栓形成伴血小板减少综合征的临床病理特征及澳大利亚的病例结局:一项基于人群的研究。
Lancet Reg Health West Pac. 2023 Sep 4;40:100894. doi: 10.1016/j.lanwpc.2023.100894. eCollection 2023 Nov.
7
Lessons Learnt from Case Series of Out-of-hospital Cardiac Arrest and Unexpected Death after COVID-19 Vaccination.从 COVID-19 疫苗接种后院外心脏骤停和意外死亡的病例系列中吸取的教训。
Intern Med. 2023 Nov 15;62(22):3267-3275. doi: 10.2169/internalmedicine.2298-23. Epub 2023 Aug 23.
8
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand.泰国新冠疫苗接种后的心肌炎和心包炎
Vaccines (Basel). 2023 Mar 28;11(4):749. doi: 10.3390/vaccines11040749.
9
SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity.SARS-CoV-2 mRNA 疫苗使抗病毒免疫与体液自身免疫脱钩。
Nat Commun. 2023 Mar 9;14(1):1299. doi: 10.1038/s41467-023-36686-8.
10
Myocardial infarction or myocarditis? A case report and review of a myocardial adverse event associated with mRNA vaccine.心肌梗死还是心肌炎?一例与mRNA疫苗相关的心肌不良事件的病例报告及文献综述。
Front Med (Lausanne). 2023 Feb 2;10:1071239. doi: 10.3389/fmed.2023.1071239. eCollection 2023.
他汀类药物治疗与冠状动脉粥样硬化斑块成分进展的关系。
JAMA Cardiol. 2021 Nov 1;6(11):1257-1266. doi: 10.1001/jamacardio.2021.3055.
4
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.mRNA COVID-19 疫苗接种后美国军人中的心肌炎。
JAMA Cardiol. 2021 Oct 1;6(10):1202-1206. doi: 10.1001/jamacardio.2021.2833.
5
Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.疑似 COVID-19 疫苗诱导(免疫性)血栓性血小板减少症的实验室检测。
Int J Lab Hematol. 2021 Aug;43(4):559-570. doi: 10.1111/ijlh.13629. Epub 2021 Jun 17.
6
Myocarditis Temporally Associated With COVID-19 Vaccination.心肌炎与 COVID-19 疫苗接种相关。
Circulation. 2021 Aug 10;144(6):502-505. doi: 10.1161/CIRCULATIONAHA.121.055891. Epub 2021 Jun 16.
7
Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report.接种 COVID-19 疫苗后一名既往健康的青少年男性出现心肌炎:病例报告。
Acad Emerg Med. 2021 Aug;28(8):918-921. doi: 10.1111/acem.14322. Epub 2021 Jul 21.
8
Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia.疫苗诱导的免疫性血栓性血小板减少症的辅助免疫球蛋白。
N Engl J Med. 2021 Aug 19;385(8):720-728. doi: 10.1056/NEJMoa2107051. Epub 2021 Jun 9.
9
Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination.7 名青少年在接种辉瑞-BioNTech COVID-19 疫苗后出现症状性急性心肌炎。
Pediatrics. 2021 Sep;148(3). doi: 10.1542/peds.2021-052478. Epub 2021 Jun 4.
10
Myocarditis After SARS-CoV-2 Vaccination: True, True, and… Related?新型冠状病毒2型疫苗接种后的心肌炎:确有其事、确有其事,以及……有关联?
Pediatrics. 2021 Sep;148(3). doi: 10.1542/peds.2021-052644. Epub 2021 Jun 4.